The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,638,723 in first-year total cost, median $1,497,307.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-T (30)]3
Most frequent institutions
- UNIV OF MASSACHUSETTS MED SCH WORCESTER1
- UNIVERSITY OF ROCHESTER1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Training Core [Parent Title: NOVEL THERAPEUTICS FOR FSHD]2P50HD060848-12 | EMERSON, CHARLES P. | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $1,716,067 | ZNS1 |
| 2018 | Wellstone Muscular Dystrophy Specialized Research Center (Seattle)2P50AR065139-05 | CHAMBERLAIN, JEFFREY S | UNIVERSITY OF WASHINGTON, WA | $1,497,307 | ZNS1 |
| 2018 | Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center2P50NS048843-16 | THORNTON, CHARLES A | UNIVERSITY OF ROCHESTER, NY | $1,425,349 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.